Geert Vandeplassche_

Is Hemispherx BioPharma Undervalued?

A recent research report by Boenning & Scattergood can be found here: www.boenningandscatter...

Is Hemispherx BioPharma Undervalued?

This is a crucial link to Dr. Gerberding’s (of the CDC) Address at CFS Awareness Campaign Launch I forgot to add.

www.cdc.gov/cfs/PSAs/G...

Hemispherx Biopharma Is Worth The Risk

Clinical efficacy and safety data (both phase 2 and 3) of Ampligen for CFS are compelling.
Since going public, this stock has been bashed, first by Asensio, later on all the available message boards. They seem to have succeeded, as this is a highly misunderstood and undervalued stock. I'm sure the market is wrong here. Compare for instance its fundmamentals and pps to MDV's.